1. Home
  2. DORM vs TNGX Comparison

DORM vs TNGX Comparison

Compare DORM & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dorman Products Inc.

DORM

Dorman Products Inc.

N/A

Current Price

$137.43

Market Cap

4.0B

ML Signal

N/A

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

N/A

Current Price

$22.04

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DORM
TNGX
Founded
1978
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.1B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
DORM
TNGX
Price
$137.43
$22.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
13
Target Price
★ $158.13
$47.09
AVG Volume (30 Days)
248.7K
★ 4.5M
Earning Date
10-26-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
8.14
★ 26.89
EPS
★ 6.33
N/A
Revenue
★ $2,130,319,000.00
$62,384,000.00
Revenue This Year
$2.70
N/A
Revenue Next Year
$4.71
N/A
P/E Ratio
$22.50
★ N/A
Revenue Growth
6.03
★ 48.29
52 Week Low
$98.45
$7.49
52 Week High
$155.37
$34.39

Technical Indicators

Market Signals
Indicator
DORM
TNGX
Relative Strength Index (RSI) 61.66 44.10
Support Level $131.63 $20.46
Resistance Level $143.16 $22.01
Average True Range (ATR) 5.68 1.92
MACD 1.45 -0.20
Stochastic Oscillator 70.61 11.19

Price Performance

Historical Comparison
DORM
TNGX

About DORM Dorman Products Inc.

Dorman Products Inc is a supplier of original equipment parts for automobiles. It offers automotive and heavy-duty replacement parts, automotive hardware, brake parts, and fasteners for the automotive and heavy-duty aftermarket. The products are sold under the Dorman brand and its sub-brands OE Solutions, Help!, Conduct-Tite, Super ATV, etc., through aftermarket retailers, warehouse distributors, specialty markets, and salvage yards. The company operates through three business segments, which include Light Duty, Heavy Duty, and Specialty Vehicle. A majority of its revenue is generated from the Light Duty segment, which designs and markets replacement parts and fasteners mainly for passenger cars and light trucks. Geographically, it derives key revenue from the United States.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: